The FDA and Novo Nordisk are warning the public about counterfeit Ozempic injections circulating in the legitimate U.S. drug supply chain. The FDA announced the seizure of multiple batches of counterfeit Ozempic 1 mg injections, labeled with lot number PAR1229, on December 5, 2025. Their contents and safety are unverified and pose serious health risks.
MMWR field notes about Americans hospitalized after self-injecting imported Botox raise serious concerns about patient safety.
Surveys document consumer behaviors when purchasing medication from online pharmacies, finding that the public may not be aware of the dangers of IOPs.
What are the most important lessons from CNBC’s documentary about alternative funding programs (AFPs)?
CNBC aired a documentary about alternative funding programs that included interviews with PSM’s Shabbir Imber Safdar, HSI and FDA officials, as well as a representative from Gilead Sciences and from the companies supplying these drug.
The FDA warned websites in five countries to stop selling Americans unapproved cosmetic injections.
PSM sent a letter explaining how H.R. 5316 undermines critical patient safety protections.
The Maryland distributors were convicted at trial in Florida. A federal judged sentenced a pill press seller from China.
Authorities stated this was the largest single seizure of trafficked weight loss medicines worldwide.
Board member Dr. Kenneth McCall was named an associate editor of the Journal of Pharmacy and Pharmaceutical Sciences; Executive Director Shabbir Safdar joined the editorial board of the Journal of Illicit Trade, Financial Crime, and Compliance.